CNTA Centessa Pharmaceuticals Plc
Biotechnology NasdaqGS
Trading Signals (CNTA)
Overall Signal
BUY
Strong buyish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $14.76
- Medium Support $15.57
- Weak Support $16.37
Resistance Levels
- Weak Resistance $17.97
- Medium Resistance $18.77
- Strong Resistance $19.58
Stop Loss Suggestions
- Conservative $15.05
- Moderate $15.97
- Aggressive $15.17
Analyst Ratings
Current Rating
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | BUY |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | BUY |
|
Medium Term |
| Volume Indicators | BUY |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (CNTA)
Quarterly Outlook :
2025-08-21
Bullish Scenario
from current 23.01%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (20.38) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (63.70) is in bullish territory, indicating upward momentum. MACD line (0.48) is above Signal line (0.04) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.58, indicating the average weekly price range.
2025-08-21
Base Scenario
from current 9.2%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (20.38) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (63.70) is in bullish territory, indicating upward momentum. MACD line (0.48) is above Signal line (0.04) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.58, indicating the average weekly price range.
2025-08-21
Bearish Scenario
from current -18.4%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (20.38) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (63.70) is in bullish territory, indicating upward momentum. MACD line (0.48) is above Signal line (0.04) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.58, indicating the average weekly price range.
Annual Outlook
2025-08-21
Bullish Scenario
from current 46.01%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (20.38) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (63.70) is in bullish territory, indicating upward momentum. MACD line (0.48) is above Signal line (0.04) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.58, indicating the average weekly price range.
2025-08-21
Base Scenario
from current 18.4%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (20.38) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (63.70) is in bullish territory, indicating upward momentum. MACD line (0.48) is above Signal line (0.04) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.58, indicating the average weekly price range.
2025-08-21
Bearish Scenario
from current -36.81%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (20.38) indicates a developing or moderate trend. +DI > -DI suggests bullish directional bias. RSI (63.70) is in bullish territory, indicating upward momentum. MACD line (0.48) is above Signal line (0.04) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.58, indicating the average weekly price range.
Technical Analysis (CNTA)
Trend Identification
EMA
Exponential Moving Average
Current price (17.17) is above both Short MA (15.23) and Long MA (13.57). This indicates strong bullish momentum. Short MA (15.23) is above Long MA (13.57), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. MAs (15.23, 13.57, 13.74) show mixed alignment, suggesting market indecision or range-bound activity. Consider long positions. Use the MAs as dynamic support levels.
MACD
Moving Average Convergence Divergence
MACD line is above the Signal line (bullish crossover). This indicates upward momentum. Histogram (0.0700) is positive and expanding, confirming bullish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). This is a strong buy signal. Consider long positions.
ADX
Average Directional Index
ADX (31.16) indicates a strong trend is present. +DI (32.59) is above -DI (9.84), suggesting a bullish directional bias. This combination points to a strong upward trend. Consider taking long positions, as the strong upward trend is confirmed.
Momentum Measurement
RSI (2025-08-21)
Relative Strength Index
RSI (72.38) is in the overbought zone. This suggests the asset may be due for a price correction or a trend reversal downwards. Consider profit-taking or short-selling opportunities cautiously.
OBV (2025-08-21)
On-Balance Volume
OBV (9983507.00) is rising, indicating buying pressure and accumulation. Price is rising and OBV is rising. This is bullish confirmation, indicating buying pressure supports the price increase. Consider holding long positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-08-21)
Stochastic Oscillator
Stochastics (%K: 50.95, %D: 28.41) are in the neutral zone (between 20 and 80). A bullish crossover (%K above %D) is observed. This indicates upward momentum. Be cautious if it's already in the overbought region.
CCI (2025-08-21)
Commodity Channel Index
CCI (177.70) is above +100. This suggests a strong upward momentum and an overbought condition. Consider profit-taking or looking for short entries cautiously. Confirm with price action; if price is making higher highs, momentum is strong. Look for pullbacks to enter long.
Volatility Measurement
ATR (2025-08-21)
Average True Range
Current ATR is 0.8100. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-08-21)
Volatility Bands
Current price (17.17) is above the Upper Bollinger Band (17.10). This often indicates an overextended move and a potential reversal downwards, or strong upward momentum ('walking the band'). Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility. Consider shorting or taking profit on long positions, but confirm with other indicators.
Risk Management & Potential Reversals (CNTA)
SAR (2025-08-21)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 15.05 is 12.35% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2025-08-21)
Neutral
Stochastic is in neutral territory (51.0). No clear overbought/oversold signal. Current crossover status: Bullish.
RSI (2025-08-21)
Reversal Perspective
Current RSI level suggests overbought conditions, indicating potential for a bearish reversal. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-08-21)
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is above the upper band, indicating overbought conditions or strong upward momentum. Expect a potential pullback or trend exhaustion.No indication of imminent volatility expansion or reversal.
Holder List Top 20 (CNTA)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | INSTITUTIONAL | 19963157 | 14.99% | 2025-03-31 |
| Index Venture Life Associates VI Ltd | INSTITUTIONAL | 9961789 | 7.48% | 2025-03-31 |
| General Atlantic, L.P. | INSTITUTIONAL | 9681818 | 7.27% | 2025-03-31 |
| Adage Capital Partners GP L.L.C. | INSTITUTIONAL | 6954000 | 5.22% | 2025-03-31 |
| Janus Henderson Group PLC | INSTITUTIONAL | 5922486 | 4.45% | 2025-03-31 |
| Price (T.Rowe) Associates Inc | INSTITUTIONAL | 5342344 | 4.01% | 2025-03-31 |
| First Light Asset Management, LLC | INSTITUTIONAL | 4874124 | 3.66% | 2025-03-31 |
| Farallon Capital Management LLC | INSTITUTIONAL | 4334318 | 3.25% | 2025-03-31 |
| Avoro Capital Advisors LLC | INSTITUTIONAL | 4050000 | 3.04% | 2025-03-31 |
| FMR, LLC | INSTITUTIONAL | 3826194 | 2.87% | 2025-03-31 |
| T. Rowe Price Health Sciences Fund, Inc. | MUTUALFUND | 3311147 | 2.49% | 2025-03-31 |
| Fidelity Select Portfolios-Biotechnology Portfolio | MUTUALFUND | 2976494 | 2.23% | 2025-04-30 |
| JANUS INVESTMENT FUND-Janus Henderson Triton Fund | MUTUALFUND | 965194 | 0.72% | 2025-03-31 |
| American Century Mutual Funds, Inc.-SMALL CAP GROWTH FUND | MUTUALFUND | 854444 | 0.64% | 2025-03-31 |
| T. Rowe Price New Horizons Fund, Inc. | MUTUALFUND | 752344 | 0.56% | 2025-03-31 |
| Variable Insurance Products Fund III-Mid Cap Portfolio | MUTUALFUND | 702200 | 0.53% | 2025-04-30 |
| Variable Insurance Products Fund III-VIP Mid Cap Portfolio | MUTUALFUND | 702200 | 0.53% | 2025-05-31 |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | MUTUALFUND | 678965 | 0.51% | 2025-01-31 |
| JANUS INVESTMENT FUND-Janus Henderson Venture Fund | MUTUALFUND | 498852 | 0.37% | 2025-03-31 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | MUTUALFUND | 470709 | 0.35% | 2025-03-31 |